CLEARMIND MEDICINE INC.

Press Releases Clearmind Medicine Inc. Canadian Securities Exchange

Equities

CYN

CA1850534027

Delayed Canadian Securities Exchange Other stock markets			5-day change	1st Jan Change
- ^CAD	-.--%		-13.51%	-58.01%

06-20	Clearmind Medicine Secures Exclusive Global Rights to Innovative Psychedelic Compounds for PTSD Treatment	CI
06-13	Clearmind Medicine Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment	06-28	AQ
Clearmind Medicine Secured Exclusive Global Rights to Innovative Psychedelic Compounds for PTSD Treatment	06-20	AQ
Clearmind Medicine : Condensed Interim Consolidated Financial Statements Form 6 K	06-13	PU
Clearmind Medicine Revolutionizes the $13 Billion NonAlcoholic Beverages Market with its Psychedelic-Based Drink	06-11	AQ
Clearmind Medicine Advances its Proprietary Psychedelic- Based Synthetic Alcohol Beverage Product	05-13	AQ
Clearmind Medicine Advances its Proprietary Psychedelic- Based Synthetic Alcohol Beverage Product	05-10	AQ
Clearmind Medicine Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD Treatment	05-07	AQ
Clearmind Applies to Cease Being a Reporting Issuer in Canada	04-30	AQ
Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders	04-17	AQ
Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders	04-10	AQ
Clearmind Medicine CEO Issues Letter to Shareholders	04-09	AQ
Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China	03-19	AQ
Clearmind Medicine : Condensed Interim Consolidated Financial Statements - Form 6-K	03-19	PU
SciSparc Enters Collaboration for the Development of Innovative Psychedelic-Based Pharmaceuticals	22-03-08	PR
Clearmind Medicine : Appoints Distinguished Addiction Experts Professor Wim van den Brink and Professor Gabriele Fischer to Its Scientific Advisory Board	21-10-14	GL
Clearmind Medicine : to Host ‘Psychedelics for Alcoholism‘ Virtual Educational Event on October 20	21-10-01	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer